<DOC>
	<DOCNO>NCT00003931</DOCNO>
	<brief_summary>RATIONALE : Diagnostic procedure , genetic testing , may improve ability detect acute myeloid leukemia determine extent disease . PURPOSE : Diagnostic study try detect change gene patient acute myeloid leukemia .</brief_summary>
	<brief_title>Diagnostic Study Gene Alterations Patients With Acute Myeloid Leukemia</brief_title>
	<detailed_description>OBJECTIVES : - Determine frequency partial tandem duplication ALL1 ( MLL ) patient acute myeloid leukemia ( AML ) . - Determine predictive value partial tandem duplication ALL1 identify subset AML patient short duration complete remission . OUTLINE : All sample obtain specimen collect CALGB-9665 . No additional blood bone marrow sample collect . Samples examine Southern blot analysis gene rearrangement 11q23 . Samples show evidence ALL1 gene rearrangement analyze reverse transcription PCR amplification and/or cytogenetic analysis detect partial tandem duplication ALL1 .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Prior registration protocol CALGB9665 Diagnosed acute myeloid leukemia ( AML ) Treated CALGB AML treatment protocol Diagnostic bone marrow blood specimen available PATIENT CHARACTERISTICS : Age : 15</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>recurrent adult acute myeloid leukemia</keyword>
	<keyword>adult acute myeloid leukemia remission</keyword>
</DOC>